Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 3
1953 1
1954 6
1955 3
1956 1
1957 12
1958 1
1959 9
1960 3
1961 18
1962 16
1963 22
1964 27
1965 36
1966 33
1967 47
1968 60
1969 62
1970 59
1971 67
1972 42
1973 45
1974 52
1975 59
1976 55
1977 72
1978 93
1979 73
1980 84
1981 89
1982 118
1983 107
1984 130
1985 116
1986 134
1987 143
1988 215
1989 222
1990 182
1991 196
1992 214
1993 214
1994 219
1995 223
1996 257
1997 286
1998 332
1999 316
2000 370
2001 358
2002 372
2003 392
2004 395
2005 416
2006 359
2007 371
2008 433
2009 416
2010 480
2011 477
2012 508
2013 515
2014 594
2015 638
2016 648
2017 625
2018 617
2019 583
2020 596
2021 723
2022 600
2023 423
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15,339 results

Results by year

Filters applied: . Clear all
Page 1
Claudin‑9 is a novel prognostic biomarker for endometrial cancer.
Endo Y, Sugimoto K, Kobayashi M, Kobayashi Y, Kojima M, Furukawa S, Soeda S, Watanabe T, Higashi AY, Higashi T, Hashimoto Y, Fujimori K, Chiba H. Endo Y, et al. Among authors: watanabe t. Int J Oncol. 2022 Nov;61(5):135. doi: 10.3892/ijo.2022.5425. Epub 2022 Sep 21. Int J Oncol. 2022. PMID: 36129146 Free PMC article.
Human induced pluripotent stem cell-derived salivary gland organoids model SARS-CoV-2 infection and replication.
Tanaka J, Senpuku H, Ogawa M, Yasuhara R, Ohnuma S, Takamatsu K, Watanabe T, Mabuchi Y, Nakamura S, Ishida S, Sadaoka T, Takaki T, Shirota T, Shimane T, Inoue T, Sakai T, Mori M, Tsuji T, Saito I, Mishima K. Tanaka J, et al. Among authors: watanabe t. Nat Cell Biol. 2022 Nov;24(11):1595-1605. doi: 10.1038/s41556-022-01007-6. Epub 2022 Oct 17. Nat Cell Biol. 2022. PMID: 36253535
A phase 1 trial of NY-ESO-1-specific TCR-engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma.
Ishihara M, Nishida Y, Kitano S, Kawai A, Muraoka D, Momose F, Harada N, Miyahara Y, Seo N, Hattori H, Takada K, Emori M, Kakunaga S, Endo M, Matsumoto Y, Sasada T, Sato E, Yamada T, Matsumine A, Nagata Y, Watanabe T, Kageyama S, Shiku H. Ishihara M, et al. Among authors: watanabe t. Int J Cancer. 2023 Jun 15;152(12):2554-2566. doi: 10.1002/ijc.34453. Epub 2023 Feb 17. Int J Cancer. 2023. PMID: 36727538 Clinical Trial.
Advances in Cardiac Tissue Engineering.
Kitsuka T, Takahashi F, Reinhardt J, Watanabe T, Ulziibayar A, Yimit A, Kelly J, Shinoka T. Kitsuka T, et al. Among authors: watanabe t. Bioengineering (Basel). 2022 Nov 16;9(11):696. doi: 10.3390/bioengineering9110696. Bioengineering (Basel). 2022. PMID: 36421097 Free PMC article. Review.
Tuning Rex rules HTLV-1 pathogenesis.
Nakano K, Watanabe T. Nakano K, et al. Among authors: watanabe t. Front Immunol. 2022 Sep 16;13:959962. doi: 10.3389/fimmu.2022.959962. eCollection 2022. Front Immunol. 2022. PMID: 36189216 Free PMC article. Review.
Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter study.
Atsukawa M, Tsubota A, Kondo C, Koyano KS, Ishikawa T, Toyoda H, Takaguchi K, Watanabe T, Matsuura K, Ogawa C, Hiraoka A, Okubo H, Tateyama M, Uojima H, Nozaki A, Chuma M, Kato K, Mikami S, Tani J, Morishita A, Kawata K, Tada T, Furuichi Y, Okubo T, Kawano T, Arai T, Kawabe N, Kawamura N, Ikegami T, Nakamuta M, Shigefuku R, Iwasa M, Tanaka Y, Hatano M, Iwakiri K. Atsukawa M, et al. Among authors: watanabe t. Hepatol Int. 2023 Feb;17(1):139-149. doi: 10.1007/s12072-022-10456-y. Epub 2022 Dec 7. Hepatol Int. 2023. PMID: 36477691 Clinical Trial.
Advances in Adjuvanted Influenza Vaccines.
Shichinohe S, Watanabe T. Shichinohe S, et al. Among authors: watanabe t. Vaccines (Basel). 2023 Aug 21;11(8):1391. doi: 10.3390/vaccines11081391. Vaccines (Basel). 2023. PMID: 37631959 Free PMC article. Review.
Biweekly TAS-102 and bevacizumab as third-line chemotherapy for advanced or recurrent colorectal cancer: a phase II, multicenter, clinical trial (TAS-CC4 study).
Matsuoka H, Yamada T, Ohta R, Yoshida Y, Watanabe T, Takahashi M, Kosugi C, Fukazawa A, Kuramochi H, Matsuda A, Sonoda H, Yoshida H, Hasegawa S, Sakamoto K, Otsuka T, Hirata K, Koda K; TAS CC4 Study Group. Matsuoka H, et al. Among authors: watanabe t. Int J Clin Oncol. 2022 Dec;27(12):1859-1866. doi: 10.1007/s10147-022-02243-4. Epub 2022 Oct 6. Int J Clin Oncol. 2022. PMID: 36201089 Clinical Trial.
Proprioception and Geriatric Low Back Pain.
Sakai Y, Watanabe T, Wakao N, Matsui H, Osada N, Sugiura T, Morita Y, Kawai K, Ito T, Yamazaki K. Sakai Y, et al. Among authors: watanabe t. Spine Surg Relat Res. 2022 Apr 12;6(5):422-432. doi: 10.22603/ssrr.2021-0269. eCollection 2022 Sep 27. Spine Surg Relat Res. 2022. PMID: 36348676 Free PMC article. Review.
15,339 results
You have reached the last available page of results. Please see the User Guide for more information.